Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Seligman, J. Papassotiriou, N. Morgenthaler, B. Seligman, P. Teixeira (Porto Alegre, Brazil; Hennigsdorf/Berlin, Germany). Copeptin and prognosis of ventilator-associated pneumonia. Eur Respir J 2008; 32: Suppl. 52, 2305

Member's Comments

No comment yet.

Related content which might interest you: MR-proANP and prognosis of ventilator-associated pneumonia Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Source: Eur Respir Rev, 29 (157) 200023; 10.1183/16000617.0023-2020 Year: 2020 Predictive value of procalcitonin in ventilator-associated pneumonia Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Thrombocytosis is a marker of poor outcome in community-acquired pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Diagnosis of ventilator-associated pneumonia Source: Annual Congress 2007 - Pulmonary infections and inflammation Year: 2007 Specific treatment failure of the ventilator-associated pneumonia (VAP): predictive values Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006 Prediction of prognosis in healthcare-associated pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Treatment failure of severe and ventilator-associated pneumonia Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 The impact of inflammatory-response in the outcome of trauma patients with and without ventilator-associated pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 232s Year: 2004 Biomarkers as complication predictors in community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 How to prevent ventilator-associated pneumonia Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies Year: 2013 Hospital-acquired and ventilator-associated pneumonia Source: ERS Courses: Paediatric respiratory infections Year: 2019 Preventing ventilator-associated pneumonia Source: International Congress 2017 – PG12 Life-threatening pulmonary infections Year: 2017 Evidence on measures for the prevention of ventilator-associated pneumonia Source: Eur Respir J 2007; 30: 1193-1207 Year: 2007 Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Source: Eur Respir J 2009; 34: 1364-1375 Year: 2009